Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3071)
All Articles published online
|
Oct 15, 2003 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003; 9(10): 2202-2206 [PMID: 14562378 DOI: 10.3748/wjg.v9.i10.2202] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i10/2202.htm |
| Number | Citing Articles |
| 1 |
Eva Grafström, Suzanne Egyházi, Ulrik Ringborg, Johan Hansson, Anton Platz. Biallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival. Clinical Cancer Research 2005; 11(8): 2991 doi: 10.1158/1078-0432.CCR-04-1731
|
| 2 |
Kewei Jiang, Zhanlong Shen, Yingjiang Ye, Xiaodong Yang, Shan Wang. A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scandinavian Journal of Gastroenterology 2010; 45(7-8): 898 doi: 10.3109/00365520903242580
|
| 3 |
Yan-Zhi Chen, Dan Liu, Yu-Xia Zhao, He-Tong Wang, Ya Gao, Ying Chen. Relationships Betweenp16Gene Promoter Methylation and Clinicopathologic Features of Colorectal Cancer: A Meta-Analysis of 27 Cohort Studies. DNA and Cell Biology 2014; 33(10): 729 doi: 10.1089/dna.2013.2253
|
| 4 |
Yu-Hua Hu, Chun-Ye Zhang, Zhen Tian, Li-Zhen Wang, Jiang Li. Aberrant Protein Expression and Promoter Methylation of p16 Gene Are Correlated With Malignant Transformation of Salivary Pleomorphic Adenoma. Archives of Pathology & Laboratory Medicine 2011; 135(7): 882 doi: 10.5858/2010-0181-OARI.1
|
| 5 |
Zahra Heidari, Hamidreza Mahmoudzadeh Sagheb, Enam Alhagh Charkhat Gorgich. Immunohistochemical Expression of P16ink4a in Colorectal Adenocarcinoma Compared to Adenomatous and Normal Tissue Samples: A Study on Southeast Iranian Samples. Iranian Red Crescent Medical Journal 2017; 19(6) doi: 10.5812/ircmj.15174
|
| 6 |
Carolin G�tz, Oliver Bissinger, Christopher Nobis, Klaus Wolff, Enken Drecoll, Andreas Kolk. ALDH1 as a prognostic marker for lymph node metastasis in OSCC. Biomedical Reports 2018; doi: 10.3892/br.2018.1131
|
| 7 |
Shingo Kamoshida, Hiroshi Matsuoka, Kazuya Shiogama, Atsuji Matsuyama, Ryoichi Shimomura, Ken‐ichi Inada, Morito Maruta, Yutaka Tsutsumi. Immunohistochemical analysis of thymidylate synthase, p16INK4a, cyclin‐dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: Significance of p16INK4a‐mediated cellular arrest as an indicator of chemosensitivity to 5‐fluorouracil. Pathology International 2004; 54(8): 564 doi: 10.1111/j.1440-1827.2004.01665.x
|
| 8 |
YONG JUNG, KYEUNG MIN JOO, DONG HO SEONG, YOON-LA CHOI, DOO-SIK KONG, YONGHYUN KIM, MI HYUN KIM, JUYOUN JIN, YEON-LIM SUH, HO JUN SEOL, CHUL SOO SHIN, JUNG-IL LEE, JONG-HYUN KIM, SANG YONG SONG, DO-HYUN NAM. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. International Journal of Oncology 2012; 40(4): 1122 doi: 10.3892/ijo.2011.1302
|
| 9 |
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, Andreas M. Luebke, Martina Kluth, Franziska Büscheck, Claudia Hube-Magg, Doris Höflmayer, Natalia Gorbokon, Sören Weidemann, Katharina Möller, Christoph Fraune, Christian Bernreuther, Ronald Simon, Christian Kähler, Anne Menz, Andrea Hinsch, Frank Jacobsen, Patrick Lebok, Till Clauditz, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Eike Burandt, Rainer Krech, David Dum, Till Krech, Andreas Marx, Sarah Minner, Surinder K. Batra. High prevalence of p16 staining in malignant tumors. PLOS ONE 2022; 17(7): e0262877 doi: 10.1371/journal.pone.0262877
|
| 10 |
Zhen Wang, Fang Wang, Wei-Qi Wang, Qian Gao, Wan-Li Wei, Yun Yang, Guo-Ying Wang. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World Journal of Gastroenterology 2004; 10(4): 550-554 doi: 10.3748/wjg.v10.i4.550
|
| 11 |
Ning Zhou, Quankai Gu. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer. Medicine 2018; 97(12): e0195 doi: 10.1097/MD.0000000000010195
|
| 12 |
Yan Shi, Zhi Rong Qian, Sui Zhang, Wanwan Li, Yohei Masugi, Tingting Li, Jennifer A. Chan, Juhong Yang, Annacarolina Da Silva, Mancang Gu, Li Liu, Tsuyoshi Hamada, Keisuke Kosumi, Trevor Dutton, Lauren K. Brais, Reiko Nishihara, Charles S. Fuchs, Shuji Ogino, Matthew H. Kulke. Cell Cycle Protein Expression in Neuroendocrine Tumors. Pancreas 2017; 46(10): 1347 doi: 10.1097/MPA.0000000000000944
|
| 13 |
Amriti R. Lulla, Michael J. Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El-Deiry. miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells. Cancer Research 2017; 77(24): 6902 doi: 10.1158/0008-5472.CAN-17-1767
|
| 14 |
Sonal M Manohar. Cyclin-dependent kinases as potential targets for colorectal cancer: past, present and future. Future Medicinal Chemistry 2022; 14(14): 1087 doi: 10.4155/fmc-2022-0064
|
| 15 |
Sameh Mikhail, Christopher Albanese, Michael J. Pishvaian. Cyclin-Dependent Kinase Inhibitors and the Treatment of Gastrointestinal Cancers. The American Journal of Pathology 2015; 185(5): 1185 doi: 10.1016/j.ajpath.2015.01.008
|
| 16 |
Mária Štorcelová, Marián Vicián, Richard Reis, Michal Zeman, Iveta Herichová. Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue. Molecular Biology Reports 2013; 40(11): 6351 doi: 10.1007/s11033-013-2749-2
|
| 17 |
Olavo Magalhães PICANÇO-JUNIOR, Thérèse Rachell THEODORO, Paulo José de Brito Silva ALBUQUERQUE, Rodrigo Nascimento PINHEIRO, Jaques WAISBERG. PRESENÇA DO PAPILOMAVIRUS HUMANO TIPO 16 E EXPRESSÃO GÊNICA DA PROTEÍNA P16INK4A E ONCOPROTEÍNA E7 NO CARCINOMA COLORRETAL. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2021; 34(4) doi: 10.1590/0102-672020210002e1637
|
| 18 |
Chunzhi Qin, Qin Zhang, Guangbin Wu. RANBP9 suppresses tumor proliferation in colorectal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10134
|
| 19 |
Mansour K. Gatasheh, Sathan Raj Natarajan, Rajapandiyan Krishnamoorthy, Tawfiq S Alsulami, Ponnulakshmi Rajagopal, Chella Perumal Palanisamy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman. Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis. Molecular & Cellular Oncology 2024; 11(1) doi: 10.1080/23723556.2024.2326699
|
| 20 |
Susan Ann Burchill. Molecular abnormalities in Ewing’s sarcoma. Expert Review of Anticancer Therapy 2008; 8(10): 1675 doi: 10.1586/14737140.8.10.1675
|
| 21 |
Xiao-li Feng, Ling Li, Yan-ning Gao, Jian-jun Zhang, Ting Xiao, Jian-ming Ying, Ji-dong Gao, Yun-tian Sun, Shu-jun Cheng. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer. Medical Oncology 2011; 28(1): 336 doi: 10.1007/s12032-010-9452-0
|
| 22 |
Ana Paula Franco Lambert, Fernando Anschau, Virgínia Minghelli Schmitt. p16INK4A expression in cervical premalignant and malignant lesions. Experimental and Molecular Pathology 2006; 80(2): 192 doi: 10.1016/j.yexmp.2005.08.005
|
| 23 |
Rehab A. Karam, Haidy E. Zidan, Tamer M. Abd Elrahman, Samir A. Badr, Samar A. Amer. Study of p16 promoter methylation in Egyptian colorectal cancer patients. Journal of Cellular Biochemistry 2019; 120(5): 8581 doi: 10.1002/jcb.28146
|
| 24 |
B. Sis, A. Tasanarong, F. Khoshjou, F. Dadras, K. Solez, P.F. Halloran. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney International 2007; 71(3): 218 doi: 10.1038/sj.ki.5002039
|
| 25 |
Muhamad Thohar Arifin, Seiji Hama, Yoshinori Kajiwara, Kazuhiko Sugiyama, Taiichi Saito, Shinya Matsuura, Fumiyuki Yamasaki, Kazunori Arita, Kaoru Kurisu. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. Journal of Neuro-Oncology 2006; 77(3): 273 doi: 10.1007/s11060-005-9037-5
|
| 26 |
Jian-Ying Zhang, Roxanne Megliorino, Xuan-Xian Peng, Eng M. Tan, Yao Chen, Edward K.L. Chan. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Journal of Hepatology 2007; 46(1): 107 doi: 10.1016/j.jhep.2006.08.010
|
| 27 |
Yue Liu, Xiufeng Zhong, Shangtao Wan, Wenxin Zhang, Jianxian Lin, Ping Zhang, Yongping Li. p16INK4a expression in retinoblastoma: a marker of differentiation grade. Diagnostic Pathology 2014; 9(1) doi: 10.1186/s13000-014-0180-1
|
| 28 |
Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Olalekan Olanrewaju Bakare, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. Biotechnology Reports 2021; 29: e00602 doi: 10.1016/j.btre.2021.e00602
|
| 29 |
John Griniatsos, Othon P Michail, Stamatios Theocharis, Antonios Arvelakis, Ioannis Papaconstantinou, Evangelos Felekouras, Emmanouel Pikoulis, Ioannis Karavokyros, Chris Bakoyiannis, George Marinos, John Bramis, Panayiotis O Michail. Circadian variation in expression of G<sub>1</sub> phase cyclins D<sub>1</sub> and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa. World Journal of Gastroenterology 2006; 12(13): 2109-2114 doi: 10.3748/wjg.v12.i13.2109
|
| 30 |
Antoine Italiano, Laurence Bianchini, Elisabet Gjernes, Frédérique Keslair, Dominique Ranchere-Vince, Jean-Marc Dumollard, Juliette Haudebourg, Agnès Leroux, Claire Mainguené, Philippe Terrier, Frédéric Chibon, Jean-Michel Coindre, Florence Pedeutour. Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas. Clinical Cancer Research 2009; 15(18): 5696 doi: 10.1158/1078-0432.CCR-08-3185
|
| 31 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Damak, Lobna Ayadi, Abdelmajid Khabir, Ali Amouri, Foued Frikha, Sameh Ellouz, Mounir Frikha, Tahia Sellami-Boudawara, Raja Mokdad-Gargouri. Expression of p16INK4a, Alone or Combined With p53, is Predictive of Better Prognosis in Colorectal Adenocarcinoma in Tunisian Patients. Applied Immunohistochemistry & Molecular Morphology 2011; 19(6): 562 doi: 10.1097/PAI.0b013e3182143380
|
| 32 |
Vanessa Deschoolmeester, Veerle Van Marck, Marc Baay, Christine Weyn, Peter Vermeulen, Eric Van Marck, Filip Lardon, Veronique Fontaine, Jan B Vermorken. Detection of HPV and the role of p16INK4Aoverexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-117
|
| 33 |
Alexandra Palmer, Sarah Epton, Ellie Crawley, Marilisa Straface, Luke Gammon, Meghan M. Edgar, Yichen Xu, Shezan Elahi, Joanne Chin-Aleong, Joanne E. Martin, Cleo L. Bishop, Charles H. Knowles, Gareth J. Sanger. Expression of p16 Within Myenteric Neurons of the Aged Colon: A Potential Marker of Declining Function. Frontiers in Neuroscience 2021; 15 doi: 10.3389/fnins.2021.747067
|
| 34 |
Alfred King-Yin Lam, Kate Ong, Yik-Hong Ho. Colorectal Mucinous Adenocarcinoma: The Clinicopathologic Features and Significance of p16 and p53 Expression. Diseases of the Colon & Rectum 2006; 49(9): 1275 doi: 10.1007/s10350-006-0650-y
|
| 35 |
Ana Martínez-Val, Kyle Fort, Claire Koenig, Leander Van der Hoeven, Giulia Franciosa, Thomas Moehring, Yasushi Ishihama, Yu-ju Chen, Alexander Makarov, Yue Xuan, Jesper V. Olsen. Hybrid-DIA: intelligent data acquisition integrates targeted and discovery proteomics to analyze phospho-signaling in single spheroids. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-39347-y
|
| 36 |
Anja Geßner, Angelika Borkowetz, Michael Baier, Angela Göhlert, Torsten Wilhelm, Alexander Thumbs, Eric Borgstein, Lars Jansen, Katrin Beer, Henning Mothes, Matthias Dürst. Detection of HPV16 in Esophageal Cancer in a High-Incidence Region of Malawi. International Journal of Molecular Sciences 2018; 19(2): 557 doi: 10.3390/ijms19020557
|
| 37 |
Ming Yin, Sheldon Bastacky, Anil V. Parwani, Teresa McHale, Rajiv Dhir. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Human Pathology 2008; 39(4): 527 doi: 10.1016/j.humpath.2007.08.005
|
| 38 |
Afsane Bahrami, Seyed Mahdi Hassanian, Majid Khazaei, Masoumeh Gharib, Mahsa Rahmani, Hamid Fiuji, Mir Hadi Jazayeri, Mehrdad Moetamani-Ahmadi, Gordon A Ferns, Amir Avan. The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer. Pharmacogenomics 2018; 19(5): 463 doi: 10.2217/pgs-2017-0096
|
| 39 |
Ming Yin, Rajiv Dhir, Anil V Parwani. Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma. Diagnostic Pathology 2007; 2(1) doi: 10.1186/1746-1596-2-41
|
| 40 |
K Evangelou, J Bramis*, I Peros, P Zacharatos, D Dasiou-Plakida, N Kalogeropoulos, PJ Asimacopoulos, C Kittas, E Marinos, VG Gorgoulis. Electron microscopy evidence that cytoplasmic localization of the p16INK4A“nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas. Biotechnic & Histochemistry 2004; 79(1): 5 doi: 10.1080/10520290310001659466
|
| 41 |
Minjin Lee, Woon Sup Han, Ok Kyoung Kim, Sun Hee Sung, Min Sun Cho, Shi Nae Lee, Heasoo Koo. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Pathology - Research and Practice 2006; 202(6): 415 doi: 10.1016/j.prp.2005.11.011
|
| 42 |
C S Roxburgh, C H Richards, A I MacDonald, A G Powell, L M McGlynn, D C McMillan, P G Horgan, J Edwards, P G Shiels. The in situ local immune response, tumour senescence and proliferation in colorectal cancer. British Journal of Cancer 2013; 109(8): 2207 doi: 10.1038/bjc.2013.556
|
| 43 |
Elizabeth Ball, Jane Bond, Brigitte Franc, Catherine DeMicco, David Wynford-Thomas. An immunohistochemical study of p16INK4a expression in multistep thyroid tumourigenesis. European Journal of Cancer 2007; 43(1): 194 doi: 10.1016/j.ejca.2006.08.025
|
| 44 |
Po Zhao, Xin Mao, Ian C Talbot. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World Journal of Gastroenterology 2006; 12(39): 6391-6396 doi: 10.3748/wjg.v12.i39.6391
|
| 45 |
Kaori Shima, Katsuhiko Nosho, Yoshifumi Baba, Mami Cantor, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Charles S. Fuchs, Shuji Ogino. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. International Journal of Cancer 2011; 128(5): 1080 doi: 10.1002/ijc.25432
|
| 46 |
Antonio Giordano, Marcella Macaluso. Prognostic significance of pRb family and p16INK4 alterations in colorectal cancer: An interesting point of view in a complex net of molecular signals. Human Pathology 2004; 35(10): 1171 doi: 10.1016/j.humpath.2004.09.001
|
| 47 |
S C Brownhill, C Taylor, S A Burchill. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. British Journal of Cancer 2007; 96(12): 1914 doi: 10.1038/sj.bjc.6603819
|
| 48 |
Stephen O. Ikuerowo, Markus A. Kuczyk, Reinhard von Wasielewski, Olayiwola B. Shittu, Udo Jonas, Stefan Machtens, Jürgen Serth. p16INK4a Expression and Clinicopathologic Parameters in Renal Cell Carcinoma. European Urology 2007; 51(3): 732 doi: 10.1016/j.eururo.2006.08.010
|
| 49 |
Thomas A. Peterson, Iris Ivy M. Gauran, Junyong Park, DoHwan Park, Maricel G. Kann, Marco Punta. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples. PLOS Computational Biology 2017; 13(4): e1005428 doi: 10.1371/journal.pcbi.1005428
|
| 50 |
Min-Kyoung Shin, Yong-Deok Jeon, Seung-Heon Hong, Sa-Haeng Kang, Ji-Ye Kee, Jong-Sik Jin. In Vivo and In Vitro Effects of Tracheloside on Colorectal Cancer Cell Proliferation and Metastasis. Antioxidants 2021; 10(4): 513 doi: 10.3390/antiox10040513
|
| 51 |
Alfred King-Yin Lam, Kate Ong, Mahmound Jafari Giv, Yik-Hong Ho. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008; 40(6): 580 doi: 10.1080/00313020802320713
|
| 52 |
Saber A. Sakr, Moshera M. Abdel-Wahed, Doaa G. El-Sahra. Immunohistochemical differential diagnosis between urothelial carcinoma and prostate adenocarcinoma among Egyptian patients. Biomedicine & Pharmacotherapy 2014; 68(6): 685 doi: 10.1016/j.biopha.2014.08.003
|
| 53 |
Paul M. Weinberger, Z. Yu, B.G. Haffty, D. Kowalski, M. Harigopal, C. Sasaki, D. L. Rimm, A. Psyrri. Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer. Clinical Cancer Research 2004; 10(17): 5684 doi: 10.1158/1078-0432.CCR-04-0448
|
| 54 |
Oana-Maria Thoma, Markus F. Neurath, Maximilian J. Waldner. Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.757120
|
| 55 |
Narikazu Uzawa, Itaru Sonoda, Kunihiro Myo, Ken‐Ichiro Takahashi, Ryozo Miyamoto, Teruo Amagasa. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas. Cancer 2007; 110(10): 2230 doi: 10.1002/cncr.23030
|